Dopamine D2 receptor availability and amphetamine-induced dopamine release in unipolar depression

A rating scale for depression

Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · see citing works

The Brief Psychiatric Rating Scale.

Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090 · see citing works

The Structured Clinical Interview for DSM-III-R (SCID): I: History, Rationale, and Description

Spitzer, R. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820080032005 · Cited by 4,336 · see citing works

Psychopharmacology: The Fourth Generation of Progress

Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985 · see citing works

From motivation to action: Functional interface between the limbic system and the motor system

MOGENSON, G., JONES, D., & YIM, C. (1980) · Progress in Neurobiology · doi:10.1016/0301-0082(80)90018-0 · Cited by 2,331 · see citing works

Negative Symptoms in Schizophrenia: Definition and Reliability

Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070020005 · Cited by 2,247 · see citing works

Brain Dopamine and Reward

Wise, R. A., & Rompre, P.-P. (1989) · Annual Review of Psychology · doi:10.1146/annurev.ps.40.020189.001203 · Cited by 1,968 · see citing works

Rapid Automated Algorithm for Aligning and Reslicing PET Images

Woods, R. P., Cherry, S. R., & Mazziotta, J. C. (1992) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199207000-00024 · Cited by 1,932 · see citing works

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

Laruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9235 · Cited by 1,291 · see citing works

Chronic mild stress-induced anhedonia: A realistic animal model of depression

Willner, P., Muscat, R., & Papp, M. (1992) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80194-0 · Cited by 1,160 · see citing works

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method

Breier, A., Su, T.-P., Saunders, R., Carson, R. E., Kolachana, B. S., de Bartolomeis, A., Weinberger, D. R., Weisenfeld, N., Malhotra, A. K., Eckelman, W. C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2569 · Cited by 1,154 · see citing works

Increased baseline occupancy of D ₂ receptors by dopamine in schizophrenia

Abi-Dargham, A., Rodenhiser, J., Printz, D., Zea-Ponce, Y., Gil, R., Kegeles, L. S., Weiss, R., Cooper, T. B., Mann, J. J., Van Heertum, R. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.8104 · Cited by 1,020 · see citing works

Imaging Synaptic Neurotransmission with <i>in Vivo</i> Binding Competition Techniques: A Critical Review

Laruelle, M. (2000) · Journal of Cerebral Blood Flow &amp; Metabolism · doi:10.1097/00004647-200003000-00001 · Cited by 944 · see citing works

Reward processing in primate orbitofrontal cortex and basal ganglia

Schultz, W. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.3.272 · Cited by 942 · see citing works

Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort.

Abi-Dargham, A., Gil, R. B., Krystal, J., Baldwin, R., Seibyl, J., Bowers, M., van Dyck, C., Charney, D., Innis, R., & Laruelle, M. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.6.761 · Cited by 860 · see citing works

Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects

Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gatley, S. J., Hitzemann, R., Chen, A. D., Dewey, S. L., & Pappas, N. (1997) · Nature · doi:10.1038/386830a0 · Cited by 854 · see citing works

Increased dopamine transmission in schizophrenia: relationship to illness phases.

Laruelle, M., Abi-Dargham, A., Gil, R. B., Kegeles, L., & Innis, R. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00067-0 · Cited by 744 · see citing works

Reduced brain serotonin transporter availability in major depression as measured by [123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography

Malison, R. T., Price, L. H., Berman, R., van Dyck, C. H., Pelton, G. H., Carpenter, L., Sanacora, G., Owens, M. J., Nemeroff, C. B., Rajeevan, N., et al. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00272-8 · Cited by 496 · see citing works

Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.

Kegeles, L., Abi-Dargham, A., Zea-Ponce, Y., Rodenhiser-Hill, J., Mann, J., Heertum, R. V. V., Cooper, T. B., Carlsson, A., & Laruelle, M. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00976-8 · Cited by 425 · see citing works

Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress

Kalivas, P. W., & Duffy, P. (1995) · Brain Research · doi:10.1016/0006-8993(95)00013-g · Cited by 395 · see citing works

Comparison of Bolus and Infusion Methods for Receptor Quantitation: Application to [ 18 F]Cyclofoxy and Positron Emission Tomography

Carson, R. E., Channing, M. A., Blasberg, R. G., Dunn, B. B., Cohen, R. M., Rice, K. C., & Herscovitch, P. (1993) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1993.6 · Cited by 376 · see citing works

Dopamine and depression

Brown, A. S., & Gershon, S. (1993) · Journal of Neural Transmission · doi:10.1007/bf01245227 · Cited by 359 · see citing works

Role of the dopaminergic system in depression

Kapur, S., & Mann, J. J. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90137-o · Cited by 350 · see citing works

SPECT imaging of striatal dopamine release after amphetamine challenge.

Laruelle, M. A., Abi‐Dargham, A., van Dyck, C. H., Rosenblatt, W., Zea‐Ponce, Y., Zoghbi, S. S., Baldwin, R. M., Charney, D. S., Hoffer, P. B., & Kung, H. F. (1995) · PubMed · Cited by 333 · see citing works

Low Dopamine D 2 Receptor Binding Potential in Social Phobia

Schneier, F. R., Liebowitz, M. R., Abi‐Dargham, A., Zea‐Ponce, Y., Lin, S., & Laruelle, M. A. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.3.457 · Cited by 325 · see citing works

Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress

Deutch, A. Y., Clark, W. A., & Roth, R. H. (1990) · Brain Research · doi:10.1016/0006-8993(90)91557-w · Cited by 302 · see citing works

Amphetamine and Other Weak Bases Act to Promote Reverse Transport of Dopamine in Ventral Midbrain Neurons

Sulzer, D. L., Maidment, N. T., & Rayport, S. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03181.x · Cited by 292 · see citing works

Current Developments in Psychopharmacology

Essman, W. B., & Valzelli, L. (1981) · Springer eBooks · doi:10.1007/978-94-011-8123-5 · Cited by 291 · see citing works

Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence

Hietala, J., West, C., Syvälahti, E., Någren, K., Lehikoinen, P., Sonninen, P., & Ruotsalainen, U. (1994) · Psychopharmacology · doi:10.1007/bf02245330 · Cited by 269 · see citing works

Imaging D2 Receptor Occupancy by Endogenous Dopamine in Humans

Laruelle, M. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00043-2 · Cited by 266 · see citing works

Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates

Laruelle, M. A., Iyer, R. N., Al‐Tikriti, M. S., Zea‐Ponce, Y., Malison, R. T., Zoghbi, S. S., Baldwin, R. M., Kung, H. F., Charney, D. S., Hoffer, P. B., et al. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199701)25:1 · Cited by 264 · see citing works

Brain SPECT Imaging of Amphetamine-Induced Dopamine Release in Euthymic Bipolar Disorder Patients

Anand, A., Verhoeff, P., Seneca, N., Zoghbi, S. S., Seibyl, J. P., Charney, D. S., & Innis, R. B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.7.1108 · Cited by 222 · see citing works

D2 dopamine receptors and personality traits

Farde, L., Gustavsson, P. J., & Jönsson, E. G. (1997) · Nature · doi:10.1038/385590a0 · Cited by 217 · see citing works

The role of dopamine in mood disorders

Diehl, D. J., & Gershon, S. (1992) · Comprehensive Psychiatry · doi:10.1016/0010-440x(92)90007-d · Cited by 216 · see citing works

Dopamine D2 receptors in the cerebral cortex: Distribution and pharmacological characterization with [3H]raclopride

Lidow, M. S., Goldman-Rakic, P. S., Rakic, P., & Innis, R. B. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6412 · Cited by 209 · see citing works

Dopamine D2 receptors in depression measured with single photon emission computed tomography

D'haenen, H. A., & Bossuyt, A. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)91202-5 · Cited by 189 · see citing works

Striatal dopamine transporter density in major depression

Laasonen-Balk, T., Kuikka, J. T., Viinam�ki, H., Husso, M., Lehtonen, J., & Tiihonen, J. (1999) · Psychopharmacology · doi:10.1007/s002130051005 · Cited by 172 · see citing works

Clinical and psychometric correlates of dopamine D₂ binding in depression

SHAH, P. J., OGILVIE, A. D., GOODWIN, G. M., & EBMEIER, K. P. (1997) · Psychological Medicine · doi:10.1017/s0033291797005382 · Cited by 170 · see citing works

Dopamine and depression — Striatal dopamine D2 receptor SPECT before and after antidepressant therapy

Ebert, D., Loew, T. H., Feistel, H., & Pirner, A. (1996) · Psychopharmacology · doi:10.1007/bf02246416 · Cited by 133 · see citing works

Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT

Klimke, A. (1999) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(99)00009-8 · Cited by 126 · see citing works

Dopamine D2 Receptor Density and Personal Detachment in Healthy Subjects

Breier, A. F., Kestler, L. J., Adler, C. M., Elman, I., Wiesenfeld, N., Malhotra, A. K., & Pickar, D. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.10.1440 · Cited by 119 · see citing works

Advances in Protaglandin, Thromboxane, and Leukotriene Research, Ninth International Conference on Prostaglandins and Related Compounds

Samuelsson, B., Ramwell, P. W., Paoletti, R., Folco, G., Granström, E., & Nicosia, S. (1996) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(96)85115-8 · Cited by 111 · see citing works

Compartmental modeling of iodine-123-iodobenzofuran binding to dopamine D2 receptors in healthy subjects.

Laruelle, M. A., van Dyck, C., Abi‐Dargham, A., Zea‐Ponce, Y., Ss, Z., Ds, C., Rm, B., Hoffer, P. B., Hf, K., & Rb, I. (1994) · PubMed · Cited by 92 · see citing works

Dopamine D-2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling and in vitro binding of (R)-(+)- and (S)-(-)-3-iodo-2-hydroxy-6-methoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide

Kung, H. F., Kasliwal, R., Pan, S., Kung, M. P., Mach, R. H., & Guo, Y. Z. (1988) · Journal of Medicinal Chemistry · doi:10.1021/jm00400a027 · Cited by 84 · see citing works

Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans

Kegeles, L. S., Zea‐Ponce, Y., Abi‐Dargham, A., Rodenhiser, J., Wang, T., Weiss, R., Heertum, R. L. V., Mann, J. J., & Laruelle, M. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19990315)31:4 · Cited by 80 · see citing works

Dynamic SPECT imaging of dopamine D2 receptors in human subjects with iodine-123-IBZM.

Seibyl, J. P., Sw, W., Ss, Z., Rm, B., Hm, D., Goddard, A. W., Zea‐Ponce, Y., Zubal, G. I., Germine, M., & Eo, S. (1992) · PubMed · Cited by 66 · see citing works

Prediction of imipramine antidepressant response by a one-day dextro- amphetamine trial

van Kammen, D. P., & Murphy, D. L. (1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.10.1179 · Cited by 56 · see citing works

Imaging Studies of Cocaine in the Human Brain and Studies of the Cocaine Addicta

Volkow, N. D., Wang, G., & Fowler, J. S. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb46188.x · Cited by 52 · see citing works

Unchanged density of caudate nucleus dopamine uptake sites in depressed suicide victims

Allard, P. O., & Norl�n, M. (1997) · Journal of Neural Transmission · doi:10.1007/bf01294736 · Cited by 16 · see citing works

Synthesis of [123I]IBZM: a reliable procedure for routine clinical studies

Zea‐Ponce, Y., & Laruelle, M. (1999) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(99)00031-1 · Cited by 12 · see citing works

The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway

Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693 · see citing works

Reconsidering anhedonia in depression: Lessons from translational neuroscience

Treadway, M. T., & Zald, D. H. (2011) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.06.006 · Cited by 1,579 · see citing works

Neuroimaging studies of mood disorders

Drevets, W. C. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01020-9 · Cited by 1,313 · see citing works

The role of dopamine in the pathophysiology of depression

Dunlop, B. W., & Nemeroff, C. B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.3.327 · Cited by 1,244 · see citing works

Imaging Human Mesolimbic Dopamine Transmission with Positron Emission Tomography. Part II: Amphetamine-Induced Dopamine Release in the Functional Subdivisions of the Striatum

Martinez, D., Slifstein, M., Broft, A., Mawlawi, O., Hwang, D.-R., Huang, Y., Cooper, T., Kegeles, L., Zarahn, E., Abi-Dargham, A., et al. (2003) · Journal of Cerebral Blood Flow &amp; Metabolism · doi:10.1097/01.wcb.0000048520.34839.1a · Cited by 569 · see citing works

Inflammation Effects on Motivation and Motor Activity: Role of Dopamine

Felger, J. C., & Treadway, M. T. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.143 · Cited by 453 · see citing works

Glutamate, Dopamine, and Schizophrenia: From Pathophysiology to Treatment

LARUELLE, M., KEGELES, L. S., & ABI‐DARGHAM, A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.063 · Cited by 437 · see citing works

Neurobiology of chronic mild stress: parallels to major depression

Hill, M. N., Hellemans, K. G. C., Verma, P., Gorzalka, B. B., & Weinberg, J. (2012) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.07.001 · Cited by 420 · see citing works

Neurobiology of Dopamine in Schizophrenia

Guillin, O., Abi‐Dargham, A., & Laruelle, M. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(06)78001-1 · Cited by 365 · see citing works

Review: Glutamate and dopamine dysregulation in schizophrenia — a synthesis and selective review

Stone, J., Morrison, P., & Pilowsky, L. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881106073126 · Cited by 392 · see citing works

Functional Neuroanatomical Substrates of Altered Reward Processing in Major Depressive Disorder Revealed by a Dopaminergic Probe

Tremblay, L. K., Naranjo, C. A., Graham, S. J., Herrmann, N., Mayberg, H. S., Hevenor, S., & Busto, U. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.11.1228 · Cited by 340 · see citing works

Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings

Dichter, G. S., Damiano, C. A., & Allen, J. A. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-19 · Cited by 299 · see citing works

Dopamine hypothesis of schizophrenia: Making sense of it all

Toda, M., & Abi-Dargham, A. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0041-7 · Cited by 235 · see citing works

Neurobiology of Chronic Stress-Related Psychiatric Disorders: Evidence from Molecular Imaging Studies

Davis, M. T., Holmes, S. E., Pietrzak, R. H., & Esterlis, I. (2017) · Chronic Stress · doi:10.1177/2470547017710916 · Cited by 176 · see citing works

Dopaminergic-based pharmacotherapies for depression

Papakostas, G. I. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.12.002 · Cited by 168 · see citing works

Dynamics of the dopaminergic system as a key component to the understanding of depression

Yadid, G., & Friedman, A. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00913-8 · Cited by 160 · see citing works

Elevated Putamen D ₂ Receptor Binding Potential in Major Depression With Motor Retardation: An [ ¹¹ C]Raclopride Positron Emission Tomography Study

Meyer, J. H., McNeely, H. E., Sagrati, S., Boovariwala, A., Martin, K., Verhoeff, N. P. L. G., Wilson, A. A., & Houle, S. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1594 · Cited by 160 · see citing works

Dopamine D2-Like Receptors and the Antidepressant Response

Gershon, A. A., Vishne, T. H., & Grunhaus, L. J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.031 · Cited by 159 · see citing works

In vivo vulnerability to competition by endogenous dopamine: Comparison of the D2 receptor agonist radiotracer (–)‐N‐[11C]propyl‐norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]‐raclopride

Narendran, R., Hwang, D., Slifstein, M., Talbot, P., Erritzoe, D., Huang, Y., Cooper, T. B., Martinez, D., Kegeles, L. S., Abi-Dargham, A., et al. (2004) · Synapse · doi:10.1002/syn.20013 · Cited by 156 · see citing works

Brain Imaging Studies in Mood and Anxiety Disorders

Anand, A., & Shekhar, A. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07095.x · Cited by 155 · see citing works

Pre-synaptic striatal dopaminergic function in people at high risk of psychosis

Howes, O., Montgomery, A., Asselin, M., Murray, R., Grasby, P., & McGuire, P. (2007) · The British journal of psychiatry. Supplement · doi:10.1192/bjp.191.51.s13 · Cited by 159 · see citing works

Acute prefrontal rTMS increases striatal dopamine to a similar degree as D-amphetamine

Pogarell, O., Koch, W., Pöpperl, G., Tatsch, K., Jakob, F., Mulert, C., Grossheinrich, N., Rupprecht, R., Möller, H.-J., Hegerl, U., et al. (2007) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2007.05.002 · Cited by 133 · see citing works

Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide

Abi-Dargham, A., Kegeles, L. S., Zea-Ponce, Y., Mawlawi, O., Martinez, D., Mitropoulou, V., O'Flynn, K., Koenigsberg, H. W., Van Heertum, R., Cooper, T., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.018 · Cited by 128 · see citing works

In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders.

Nikolaus, S., Antke, C., & Müller, H. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.06.009 · Cited by 137 · see citing works

Is depression associated with dysfunction of the central reward system?

Martin-Söelch, C. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370313 · Cited by 123 · see citing works

Dopamine Type-1 Receptor Binding in Major Depressive Disorder Assessed Using Positron Emission Tomography and [11C]NNC-112

Cannon, D. M., Klaver, J. M., Peck, S. A., Rallis, D., Erickson, K., & Drevets, W. C. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.194 · Cited by 119 · see citing works

Striatal Dopamine D2/3 Receptor-Mediated Neurotransmission in Major Depression: Implications for Anhedonia, Anxiety and Treatment Response

Peciña, M., Sikora, M., Avery, E. T., Heffernan, J., Peciña, S., Mickey, B., & Zubieta, J. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.08.427 · Cited by 107 · see citing works

Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: a comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride

Seneca, N., Finnema, S. J., Farde, L., Gulyás, B., Wikström, H. V., Halldin, C., & Innis, R. B. (2006) · Synapse · doi:10.1002/syn.20238 · Cited by 110 · see citing works

Psychopathological symptoms in child and adolescent migraine and tension-type headache: A meta-analysis

Balottin, U., Fusar‐Poli, P., Termine, C., Molteni, S., & Galli, F. (2012) · Cephalalgia · doi:10.1177/0333102412468386 · Cited by 105 · see citing works

The subjective and cognitive effects of acute phenylalanine and tyrosine depletion in patients recovered from depression

Roiser, J. P., McLean, A., Ogilvie, A. D., Blackwell, A. D., Bamber, D. J., Goodyer, I., Jones, P. B., & Sahakian, B. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300659 · Cited by 96 · see citing works

NMDA antagonist effects on striatal dopamine release: Positron emission tomography studies in humans

Kegeles, L., Martinez, D., Kochan, L., Hwang, D., Huang, Y., Mawlawi, O., Suckow, R., Heertum, R. V. V., & Laruelle, M. (2002) · Synapse · doi:10.1002/syn.10010 · Cited by 106 · see citing works

Striatal structure and function in mood disorders: a comprehensive review

Marchand, W. R., & Yurgelun‐Todd, D. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00874.x · Cited by 91 · see citing works

A preliminary PET evaluation of the new dopamine D2 receptor agonist [11C]MNPA in cynomolgus monkey.

Finnema, S., Seneca, N., Farde, L., Shchukin, E., Sóvágó, J., Gulyás, B., Wikström, H., Innis, R., Neumeyer, J., & Halldin, C. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2005.01.007 · Cited by 86 · see citing works

Correlation of individual differences in schizotypal personality traits with amphetamine-induced dopamine release in striatal and extrastriatal brain regions

Woodward, N. D., Cowan, R. L., Park, S., Ansari, M. S., Baldwin, R. M., Li, R., Doop, M., Kessler, R. M., & Zald, D. H. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10020165 · Cited by 90 · see citing works

Influences of dopaminergic system dysfunction on late-life depression

Taylor, W. D., Zald, D. H., Felger, J. C., Christman, S., Claassen, D. O., Horga, G., Miller, J. M., Gifford, K., Rogers, B., Szymkowicz, S. M., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01265-0 · Cited by 89 · see citing works

Striatal Dopamine in Bulimia Nervosa: a PET Imaging Study

Broft, A., Shingleton, R., Kaufman, J., Liu, F., Kumar, D. J. S., Slifstein, M., Abi-Dargham, A., Schebendach, J., Heertum, R. V. V., Attia, E., et al. (2012) · International Journal of Eating Disorders · doi:10.1002/eat.20984 · Cited by 84 · see citing works

Neuropsychiatric Adverse Effects of Amphetamine and Methamphetamine

Harro, J. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.02.004 · Cited by 84 · see citing works

A critique of the dopamine hypothesis of schizophrenia and psychosis.

Moncrieff, J. (2009) · Harvard Review of Psychiatry · doi:10.1080/10673220902979896 · Cited by 90 · see citing works

Effects of repetitive transcranial magnetic stimulation on [11C]raclopride binding and cognitive function in patients with depression

Kuroda, Y., Motohashi, N., Ito, H., Ito, S., Takano, A., Nishikawa, T., & Suhara, T. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.03.029 · Cited by 77 · see citing works

Imaging the pathophysiology of major depressive disorder - from localist models to circuit-based analysis

Treadway, M. T., & Pizzagalli, D. A. (2014) · Biology of Mood & Anxiety Disorders · doi:10.1186/2045-5380-4-5 · Cited by 75 · see citing works

Contributions from brain imaging to the elucidation of pathophysiology of bipolar disorder

Soares, J. C. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003390 · Cited by 75 · see citing works

Dopamine mediation of positive reinforcing effects of amphetamine in stimulant naïve healthy volunteers: results from a large cohort.

Abi-Dargham, A., Kegeles, L., Martinez, D., Innis, R., & Laruelle, M. (2003) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2003.08.007 · Cited by 73 · see citing works

Dopamine overflow is increased in olfactory bulbectomized rats: an in vivo microdialysis study

Masini, C. V., Holmes, P. V., Freeman, K. G., Maki, A. C., & Edwards, G. L. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.01.003 · Cited by 71 · see citing works

Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET

Hirvonen, J., Karlsson, H., Kajander, J., Markkula, J., Rasi-Hakala, H., Någren, K., Salminen, J. K., & Hietala, J. A. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1088-9 · Cited by 69 · see citing works

Greater availability of dopamine transporters in patients with major depression — A dual-isotope SPECT study

Yang, Y. K., Yeh, T. L., Yao, W. J., Lee, I. H., Chen, P. S., Chiu, N.-T., & Lu, R. B. (2008) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2007.08.008 · Cited by 69 · see citing works

Effect of amphetamine on [18F]fallypride in vivo binding to D2 receptors in striatal and extrastriatal regions of the primate brain: Single bolus and bolus plus constant infusion studies

Slifstein, M., Narendran, R., Hwang, D., Sudo, Y., Talbot, P., Huang, Y., & Laruelle, M. (2004) · Synapse · doi:10.1002/syn.20062 · Cited by 73 · see citing works

Adolescent nicotine exposure induces dysregulation of mesocorticolimbic activity states and depressive and anxiety-like prefrontal cortical molecular phenotypes persisting into adulthood

Jobson, C. L. M., Renard, J., Szkudlarek, H., Rosen, L. G., Pereira, B., Wright, D. J., Rushlow, W., & Laviolette, S. R. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhy179 · Cited by 64 · see citing works

Decreased striatal D1 binding as measured using PET and [11C]SCH 23,390 in patients with major depression with anger attacks

Dougherty, D. D., Bonab, A. A., Ottowitz, W. E., Livni, E., Alpert, N. M., Rauch, S. L., D, M. F. M., & Fischman, A. J. (2006) · Depression and Anxiety · doi:10.1002/da.20168 · Cited by 64 · see citing works

The Neurobiology of Motivational Deficits in Depression—An Update on Candidate Pathomechanisms

Treadway, M. T. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_400 · Cited by 63 · see citing works

WINCS Harmoni: Closed-loop dynamic neurochemical control of therapeutic interventions

Lee, K. H., Luján, J. L., Trevathan, J. K., Ross, E. K., Bartoletta, J. J., Park, H. O., Paek, S. B., Nicolai, E. N., Lee, J. H., Min, H.-K. P., et al. (2017) · Scientific Reports · doi:10.1038/srep46675 · Cited by 64 · see citing works

Striatal dopamine deficits predict reductions in striatal functional connectivity in major depression: a concurrent 11C-raclopride positron emission tomography and functional magnetic resonance imaging investigation

Hamilton, J. P., Sacchet, M., Hjørnevik, T., Chin, F. T., Shen, B., Kämpe, R., Park, J. H., Knutson, B., Williams, L., Borg, N., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0316-2 · Cited by 61 · see citing works

Dopamine receptor gene expression in human amygdaloid nuclei: Elevated D4 receptor mRNA in major depression

Xiang, L., Szebeni, K., Szebeni, A., Klimek, V., Stockmeier, C. A., Karolewicz, B., Kalbfleisch, J. H., & Ordway, G. A. (2008) · Brain Research · doi:10.1016/j.brainres.2008.02.009 · Cited by 60 · see citing works

Extrastriatal D2 and striatal D2 receptors in depressive illness: Pilot PET studies using [11C]FLB 457 and [11C]raclopride

Montgomery, A. J., Stokes, P. R. A., Kitamura, Y., & Grasby, P. M. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.11.010 · Cited by 58 · see citing works

Reduced striatal D2 receptor binding in myoclonus–dystonia

Beukers, R. J., Booij, J., Weisscher, N., Zijlstra, F., van Amelsvoort, T., & Tijssen, M. A. J. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0924-9 · Cited by 58 · see citing works

Molecular and neuronal mechanisms underlying the effects of adolescent nicotine exposure on anxiety and mood disorders

Laviolette, S. R. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108411 · Cited by 57 · see citing works

Decrease of the D4 dopamine receptor messenger RNA expression in lymphocytes from patients with major depression

Rocca, P., Leo, C. D., Eva, C. E., Marchiaro, L., Milani, A. M., Musso, R., Ravizza, L., Zanalda, E., & Bogetto, F. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00253-1 · Cited by 57 · see citing works

Dopamine in major depressive disorder: A systematic review and meta-analysis of in vivo imaging studies

Mizuno, Y., Ashok, A. H., Bhat, B. B., Jauhar, S., & Howes, O. D. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231200881 · Cited by 56 · see citing works

Dopaminergic activity in depressed smokers: A positron emission tomography study

Busto, U. E., Redden, L., Mayberg, H. S., Kapur, S., Houle, S., & Zawertailo, L. A. (2009) · Synapse · doi:10.1002/syn.20646 · Cited by 54 · see citing works

Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants

Mischoulon, D., Hylek, L., Yeung, A., Clain, A. J., Baer, L., Cusin, C., Ionescu, D. F., Alpert, J. E., Soskin, D. P., & D, M. F. M. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.08.029 · Cited by 55 · see citing works

Striatal dopamine type 2 receptor availability in anorexia nervosa

Broft, A. I., Slifstein, M., Osborne, J. R., Kothari, P. J., Morim, S., Shingleton, R. M., Kenney, L., Vallabhajosula, S., Attia, E., Martínez, D., et al. (2015) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2015.06.013 · Cited by 53 · see citing works

Dopamine Transmission in the Schizophrenic Brain

Laruelle, M. A. (2003) · Wiley eBooks · doi:10.1002/9780470987353.ch20 · Cited by 53 · see citing works

Neuropathological changes in the substantia nigra in schizophrenia but not depression

Williams, M. R., Galvin, K., O'Sullivan, B., Macdonald, C., Ching, E. W. K., Turkheimer, F., Howes, O., Pearce, R. K., Hirsch, S., & Maier, M. (2014) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-013-0479-z · Cited by 51 · see citing works

Antidepressant-like and antinociceptive-like actions of 4-(4′-chlorophenyl)-6-(4″-methylphenyl)-2-hydrazinepyrimidine Mannich base in mice

Rodrigues, A. L. S., Rosa, J. M., Gadotti, V. M., Goulart, E. C., Santos, M. M. M., Silva, A., Sehnem, B., Rosa, L. S., Gonçalves, R. M., Corrêa, R., et al. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.08.003 · Cited by 49 · see citing works

A review of the neurobiological underpinning of comorbid substance use and mood disorders

Gómez‐Coronado, N., Sethi, R., Bortolasci, C. C., Arancini, L., Berk, M., & Dodd, S. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.08.041 · Cited by 48 · see citing works

Postpartum and Depression Status are Associated With Lower [11C]raclopride BPND in Reproductive-Age Women

Moses‐Kolko, E. L., Price, J. C., Wisner, K. L., Hanusa, B. H., MELTZER, C. C., Berga, S. L., Grace, A. A., di Scalea, T. L., Kaye, W. H., Becker, C. R., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.328 · Cited by 46 · see citing works

Translational Research in Late-Life Mood Disorders: Implications for Future Intervention and Prevention Research

Smith, G. S., Gunning‐Dixon, F. M., Lotrich, F. E., Taylor, W. D., & Evans, J. D. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301333 · Cited by 45 · see citing works

Anhedonia in Unipolar Major Depressive Disorder: A Review~!2009-10-26~!2010-02-18~!2010-04-08~!

Dichter, G. S. (2010) · The Open Psychiatry Journal · doi:10.2174/1874354401004010001 · Cited by 50 · see citing works

Acute and Chronic Effects of Citalopram on Cerebral Glucose Metabolism in Geriatric Depression

Smith, G. S., Kramer, E., Hermann, C. R., Goldberg, S., Ma, Y., DHAWAN, V. M., Barnes, A., Chaly, T., Belakhleff, A., Laghrissi‐Thode, F., et al. (2002) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200211000-00010 · Cited by 44 · see citing works

Measuring Dopamine Synaptic Transmission with Molecular Imaging and Pharmacological Challenges: The State of the Art

Laruelle, M. (2012) · Neuromethods · doi:10.1007/7657_2012_45 · Cited by 40 · see citing works

Psychiatric disorders and headache familial recurrence: a study on 200 children and their parents

Galli, F., Canzano, L., Scalisi, T. G., & Guidetti, V. (2009) · The Journal of Headache and Pain · doi:10.1007/s10194-009-0105-7 · Cited by 45 · see citing works

Effect of a History of Major Depressive Disorder on Smoking-Induced Dopamine Release

Brody, A. L., Olmstead, R. E., Abrams, A. L., Costello, M. R., Khan, A., Kozman, D. M., Saxena, S., Farahi, J. B., London, E. D., & Mandelkern, M. A. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.06.011 · Cited by 40 · see citing works

Sunshine-exposure variation of human striatal dopamine D2/D3 receptor availability in healthy volunteers

Tsai, H.-Y., Chen, K. C., Yang, Y. K., Chen, P. S., Yeh, T. L., Chiu, N.-T., & Lee, I. H. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.09.014 · Cited by 39 · see citing works

Recent Advances in the Neurobiology of Depression

Normann, C., & Berger, T. (2003) · CRC Press eBooks · doi:10.3109/9780203002889-3 · Cited by 37 · see citing works

Anhedonia in Unipolar Major Depressive Disorder: A Review

Dichter, G. S. (2010) · The Open Psychiatry Journal · Cited by 36 · see citing works

Dopamine Release in Antidepressant-Naive Major Depressive Disorder: A Multimodal [11C]-(+)-PHNO Positron Emission Tomography and Functional Magnetic Resonance Imaging Study

Schneier, F. R., Slifstein, M., Whitton, A. E., Pizzagalli, D. A., Reinen, J., McGrath, P. J., Iosifescu, D. V., & Abi‐Dargham, A. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.05.014 · Cited by 36 · see citing works

Key players in major and bipolar depression—A retrospective analysis of in vivo imaging studies

Nikolaus, S., Hautzel, H., Heinzel, A., & Müller, H. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.03.021 · Cited by 35 · see citing works

Molecular imaging of striatal dopamine transporters in major depression—A meta-analysis

Li, Z., Hé, Y., Tang, J., Zong, X., Hu, M., & Chen, X. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.11.045 · Cited by 34 · see citing works

Acute anxiety disorder, major depressive disorder, bipolar disorder and schizophrenia are related to different patterns of nigrostriatal and mesolimbic dopamine dysfunction

Nikolaus, S., Mamlins, E., Hautzel, H., & Müller, H.-W. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0037 · Cited by 35 · see citing works

Effects of fluoxetine on dopamine D2 receptors in the human brain: a positron emission tomography study with [11C]raclopride

Penttilä, J., Kajander, J., Aalto, S., Hirvonen, J., Någren, K., Ilonen, T., Syvälahti, E. K. G., & Hietala, J. A. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570400450x · Cited by 32 · see citing works

Positron emission tomography and single photon emission CT molecular imaging in schizophrenia.

Erritzoe, D., Talbot, P., Frankle, W., & Abi-Dargham, A. (2003) · Neuroimaging clinics of North America · doi:10.1016/s1052-5149(03)00089-3 · Cited by 26 · see citing works

Recent advances in the neurobiology of depression

Normann, C., & Berger, T. (2003) · CRC Press eBooks · doi:10.3109/9780203002889-5 · Cited by 30 · see citing works

The emerging biology of delusions

Murray, G. (2010) · Psychological Medicine · doi:10.1017/s0033291710000413 · Cited by 29 · see citing works

Neuroimaging and Neuropathological Studies of Mood Disorders

Drevets, W. C., & Price, J. L. (2005) · Biology of Depression · doi:10.1002/9783527619672.ch17 · Cited by 26 · see citing works

Adolescent nicotine exposure induces long-term, sex-specific disturbances in mood and anxiety-related behavioral, neuronal and molecular phenotypes in the mesocorticolimbic system

Ng, T. H. J., Sarikahya, M. H., Hudson, R., Szkudlarek, H. J., Pérez-Valenzuela, E., Uzuneser, T. C., Proud, E., Gummerson, D., Youssef, M., Machado, M., et al. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01853-y · Cited by 23 · see citing works

Incentive salience: novel treatment strategies for major depression

Soskin, D. P., Holt, D. J., Sacco, G. R., & D, M. F. M. (2013) · CNS Spectrums · doi:10.1017/s1092852913000345 · Cited by 22 · see citing works

Molecular imaging as a guide for the treatment of central nervous system disorders

Kim, E., Howes, O., & Kapur, S. (2013) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2013.15.3/ekim · Cited by 23 · see citing works

Human dopamine receptor D2/D3 availability predicts amygdala reactivity to unpleasant stimuli

Kobiella, A., Vollstädt‐Klein, S., Fauth‐Bühler, M., Graf, C., Buchholz, H., Bernow, N., Yakushev, I. Y., Landvogt, C., Schreckenberger, M., Gründer, G., et al. (2009) · Human Brain Mapping · doi:10.1002/hbm.20900 · Cited by 21 · see citing works

Striatal Dopamine D2/3 Receptor Availability in Treatment Resistant Depression

de Kwaasteniet, B. P., Pinto, C., Ruhé, H. G., van Wingen, G. A., Booij, J., & Denys, D. A. J. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113612 · Cited by 21 · see citing works

Functional Neuroimaging in Geriatric Depression

Gunning, F. M., & Smith, G. S. (2011) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.02.010 · Cited by 21 · see citing works

Neuroreceptor imaging in psychiatry: theory and applications.

Frankle, W., Slifstein, M., Talbot, P., & Laruelle, M. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)67011-0 · Cited by 21 · see citing works

Towards a multilevel model of major depression: genes, immuno-metabolic function, and cortico-striatal signaling

Paul, E. R., Östman, L., Heilig, M. A., Mayberg, H. S., & Hamilton, J. P. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02466-7 · Cited by 16 · see citing works

Imaging synaptic dopamine availability in individuals at clinical high-risk for psychosis: a [11C]-(+)-PHNO PET with methylphenidate challenge study

Girgis, R. R., Slifstein, M., Brucato, G., Kegeles, L. S., Colibazzi, T., Lieberman, J. A., & Abi‐Dargham, A. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00934-w · Cited by 17 · see citing works

Positron Emission Tomography Molecular Imaging in Late-Life Depression

Hirao, K., & Smith, G. S. (2014) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988713516540 · Cited by 15 · see citing works

Chapter IX Human forebrain dopamine systems: Characterization of the normal brain and in relation to psychiatric disorders

Hurd, Y., & Hall, H. (2005) · Handbook of chemical neuroanatomy · doi:10.1016/s0924-8196(05)80013-2 · Cited by 16 · see citing works

Postpartum Depression

Moses‐Kolko, E. L., MELTZER, C. C., Berga, S. L., & Wisner, K. L. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374285-8.00012-3 · Cited by 13 · see citing works

Neuroreceptor Imaging of Stress and Mood Disorders

Kennedy, S. E., & Zubieta, J.-K. (2004) · CNS Spectrums · doi:10.1017/s1092852900009238 · Cited by 12 · see citing works

Neuroimaging studies of bipolar depression: functional neuropathology, treatment effects, and predictors of clinical response

Ketter, T. A., & Drevets, W. C. (2002) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(02)00043-9 · Cited by 12 · see citing works

Molecular Imaging of Depressive Disorders

Ruhé, H., Visser, A. K. D., Frokjaer, V., Haarman, B., Klein, H., & Booij, J. (2020) · PET and SPECT in Psychiatry · doi:10.1007/978-3-642-40384-2_5 · Cited by 2 · see citing works

The relation between striatal dopamine D2/D3 receptor availability and sleep quality in healthy adults

Lee, B., Chiu, N.-T., Yang, Y. K., & Chu, C. L. (2007) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e3280bad8b6 · Cited by 10 · see citing works

How schizophrenia and depression disrupt reward circuitry

Holcomb, H., & Rowland, L. (2007) · Current Treatment Options in Neurology · doi:10.1007/s11940-007-0021-6 · Cited by 8 · see citing works

Spect measurement of human striatal synaptic dopamine concentration with [123I]IBZM

Abi‐Dargham, A., Kegeles, L., Malaspina, D., Clark, S. C., Gorman, J. M., Mann, J. J., Heertum, R. V., & Laruelle, M. A. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)82502-9 · Cited by 1 · see citing works

Amphetamine-induced striatal dopamine release in major depressive disorder

Thompson, J. L., Schneier, F. R., Slifstein, M., Xu, X., Kegeles, L., Urban, N., Girgis, R. R., Laruelle, M. A., & Abi‐Dargham, A. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.04.225

Greater availability of dopamine transporters in patients with major depression — A dual-isotope SPECT study

Yang, Y. K., Yeh, T. L., Yao, W. J., Lee, I. H., Chen, P. S., Chiu, N.-T., & Lu, R. B. (2008) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2007.08.008 · Cited by 69 · see citing works

Striatal Dopamine D2/3 Receptor Availability in Treatment Resistant Depression

de Kwaasteniet, B. P., Pinto, C., Ruhé, H. G., van Wingen, G. A., Booij, J., & Denys, D. A. J. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113612 · Cited by 21 · see citing works

Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort.

Abi-Dargham, A., Gil, R. B., Krystal, J., Baldwin, R., Seibyl, J., Bowers, M., van Dyck, C., Charney, D., Innis, R., & Laruelle, M. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.6.761 · Cited by 860 · see citing works